Journal Based CME - Molecularly directed therapy of advanced/metastatic non-small cell lung cancer

Lung cancer continues to be the leading cause of cancer deaths in the United States and worldwide. This journal-based accredited continuing education (CME) activity focuses on the recent advances in molecularly directed therapy for advanced and metastatic non-small cell lung cancer. 

To read the article & Claim Credits:

Scroll down to the "Additional Information" tab to download & review the article. After reading the article, please return to this page to complete a quiz and activity evaluation to claim your CME credits!

The link to the article is also located on the program page and is hosted by the International Journal of Cancer Care and Delivery. 

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

The live portion of this activity and any associated enduring content has been supported with independent medical education grant(s) from the following companies:

  • Pfizer, Inc.
  • AstraZeneca
  • Regeneron
  • Exact Sciences
  • Jazz Pharmaceuticals

Target Audience

  • Hematologists/Oncologists
  • Oncology Nurse Practitioners
  • Oncology Pharmacists
  • Oncology Physician Assistants
  • Oncology Fellows/Residents
  • Oncology Nurses
  • Researchers and others involved in the care of cancer patients

REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($200 + 3% Credit card fee) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.

Learning Objectives

Upon successful completion of this journal-based continuing education activity, participants will be able to:

  • Identify the targeted therapies available for nine classes of mutations in NSCLC
  • Discuss the clinical trials that are laying the foundation for their use in first-line and subsequent settings of NSCLC treatment
  • Assess the current and future studies that will lead to the discovery of next-line therapies to address resistance mutations and novel targetable genes

ACCREDITATION

1.00 ABIM MOC II

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
image

1.00 AMA PRA Category 1 Credit™

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Additional Information

AttachmentSize
PDF icon Journal Article as PDF553.35 KB
Course summary
Available credit: 
  • 1.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 1.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 1.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 1.00 Contact Hours.
Course opens: 
01/17/2022
Course expires: 
01/01/2023
Cost:
$1.00

This educational activity features a journal article titled, "Molecularly directed therapy of advanced/metastatic non-small cell lung cancer" authored by Shiruyeh Schokrpur, MD, PhD & Sandip Patel, MD. Please follow the link to the article below.

Link to article: https://journal.binayfoundation.org/article/31316-molecularly-directed-therapy-of-advanced-metastatic-non-small-cell-lung-cancer

After reading the article, please return to this page to complete a quiz and evaluation to claim your Continuing Education credits!

 

No members of this activity's planning committee or faculty have any relevant financial relationship with an ineligible entity except for the following faculties. All relevant financial relationships have been identified and mitigated.

Speaker/Topic Presenter(s)

Sandip Patel, MD

has a financial relationship (Grant Or Contract) with Pfizer;.
has a financial relationship (Grant Or Contract) with BMS;.
has a financial relationship (Grant Or Contract) with AstraZeneca/MedImmune;.
has a financial relationship (Grant Or Contract) with Roche/Genentech;.
has a financial relationship (Grant Or Contract) with Merck;.

Shiruyeh Schokrpur, M.D., Ph.D.

has no relevant financial relationships to disclose at this time.

Available Credit

  • 1.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 1.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 1.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 1.00 Contact Hours.

Price

Cost:
$1.00
Please login or register to take this course.

REGISTRATION FEES:

This activity is free for all healthcare providers who are not employees of an ineligible entity. Please select "non-industry learner" when you are ready to register for the course, and the price will reset to $0. 

Healthcare providers ($0.00)

Industry employees ($200 + 3% Credit card fee) 

If you are a healthcare provider involved in patient care and you are not employed by the Industry, register for free!

If you are employed by industry, you must pay a registration fee to participate in these meetings. Any unpaid industry registrations will be invoiced $412 per participant.

 

CANCELLATION POLICY

You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, watching the recorded content, and completion of pre & post tests as well as course evaluations.

REFUND POLICY 

This activity is free for all healthcare providers who are not employees of an ineligible entity.

No refunds will be issued.